Radiesse Lidocaine
by Univerderm
Radiesse Lidocaine is a dermal tissue reconstructive material (FDA Class III; FDA product code LMH, Implant, Dermal, For Aesthetic Use) made by Univerderm, approved under FDA PMA P050052 on 22 Dec 2006 and listed in FDA GUDID since 2 Dec 2024 (UDI-DI 03770034301103), active as of 23 Oct 2026. 3 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number03770034301103 | Date2 Dec 2024 | StatusListed |
| United States | FDA PMAAPPR | NumberP050052 | Date22 Dec 2006 | StatusActive |
Official records
- AccessGUDID record 03770034301103
- FDA PMA database P050052
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA PMA P050052 decided 22 Dec 2006 Active
- FDA GUDID UDI-DI 03770034301103 listed 2 Dec 2024 Listed
Recalls
-
- Terminated Z-2607-2016
Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.
-
- Terminated Z-0145-2012
There is a potential leakage of product that may occur with Merz Aesthetics 1.5cc syringes of Radiesse Dermal Filler. When using the syringe, Health Care Professionals should be alerted to the potential for product that my leak pass the plunger at the proximal end of the syring. The defect may result in infection requiring medical intervention to prevent impairment or damage. To date Merz has n
-
- Terminated Z-2221-2011
Merz Aesthetics, Inc. is recalling 1 lot (1034417) of Radiesse 1.3 cc Implant. The lot was supposed to be scrapped because it had failed to meet its Loss On Drying (LOD) specification. Unfortunately it had been marked as approved, released and shipped.
Timeline
- Approved FDA PMA P050052
- Recall initiated FDA recalls Z-2221-2011
- Recall initiated FDA recalls Z-0145-2012
- Recall initiated FDA recalls Z-2607-2016
- Listed FDA GUDID 03770034301103
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Radiesse
- Generic name
- Dermal tissue reconstructive material, microbe-derived, anaesthetic
- Model / reference
- Lidocaine
- Primary DI / UDI-DI
- 03770034301103
- PMA number
- FDA product code
- LMH
- GMDN term
- Dermal tissue reconstructive material, microbe-derived, anaesthetic
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code LMH (Implant, Dermal, For Aesthetic Use).
- Radiesse Injectable Implant by Merz North America, Inc.
- Evolence Collagen Filler by Colbar Lifescience, Ltd.
- Restylane Refyne, Restylane Defyne Injectable Gels by Q-Med AB
- Bellafill Permanent Dermal Filler by Tiger Aesthetics Medical, LLC
- Zyderm Collagen Implant (Zyderm CI) by Allergan
- RHA 2, RHA 3, RHA 4 by Teoxane S.A.
- saypha® MagIQ™ by Croma-Pharma GmbH
- Belotero Volume (+) Lidocaine by Merz North America, Inc.
- Juvéderm Hyaluronate Gel Implants by Allergan
- Fibrel by Mentor Corp.